EMEA-001706-PIP01-14-M03
Key facts
Active substance |
Enalapril (maleate)
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0093/2021
|
PIP number |
EMEA-001706-PIP01-14-M03
|
Pharmaceutical form(s) |
Age-appropriate oral solid dosage form
|
Condition(s) / indication(s) |
Treatment of heart failure
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Proveca Pharma Limited
Tel. +353 15136233 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001706-PIP01-14-M03
|
Compliance opinion date |
25/06/2021
|
Compliance outcome |
positive
|